Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Dollar Tree (NASDAQ:DLTR): What's Behind the Stock's Continued Pre-Market Gains

Dollar Tree (NASDAQ:DLTR) shares ticked higher in pre-market trading, extending a rally that began after the company's second-quarter earnings report topped expectations by a wide margin. The move reflects continued institutional accumulation and analyst optimism following results that beat consensus on bothRevenueand earnings.

Nitish Kishor | 03 September 2026

Petco Health and Wellness (NASDAQ:WOOF): What's Behind the Stock's Pre-Market Rally

Petco Health and Wellness (NASDAQ:WOOF) shares climbed sharply in pre-market trading after the pet specialty retailer reported second-quarter results that topped profitability expectations by a wide margin, even asRevenuecame in roughly flat and slightly below estimates. The earnings beat reinforced a turnaround narrative that …

Nitish Kishor | 03 September 2026

This NYSE Retail Stock Sinks 18% Pre-Market Despite a Beat-and-Raise Quarter

A specialty apparel retailer's stock swung sharply lower in pre-market trading, reversing an earlier gain, despite reporting second-quarter results that beat expectations on nearly every headline metric and raising its full-year outlook. Net sales grew 10% year over year, comparable sales rose 9%, and …

Nitish Kishor | 03 September 2026

bioAffinity Technologies (NASDAQ:BIAF): What's Behind the Stock's 34% Pre-Market Surge

bioAffinity Technologies (NASDAQ:BIAF) shares jumped sharply in pre-market trading after the company announced it is advancing the potential application of its noninvasive lung test for surveillance of lung cancer patients following curative-intent treatment. The expanded use case targets a large and growing population of …

Nitish Kishor | 03 September 2026

Why Is CollPlant (NASDAQ:CLGN) Penny Stock Down Pre-Market Today?

CollPlant Biotechnologies (NASDAQ:CLGN) penny stock declined in pre-market trading after the company confirmed that its previously approved one-for-ten reverse share split will take effect when theNasdaqCapital Market opens on September 4, 2026. Every ten existing shares will convert into one share, with fractional shares …

Nitish Kishor | 03 September 2026

Olema Pharmaceuticals (NASDAQ:OLMA) Ticks Up Pre-Market on CFO Inducement Grant and Fresh Institutional Stake

Olema Pharmaceuticals (NASDAQ:OLMA) shares edged higher in pre-market trading after the company disclosed the terms of an inducement equity award granted to Jason V. O'Byrne, who joined as Chief Financial Officer in mid-August. The options carry an exercise price matching the stock's closing price …

Nitish Kishor | 03 September 2026

Phreesia (NYSE:PHR) Shares Fall 8% Pre-Market After Q2 Earnings Miss on Bottom Line

Phreesia (NYSE:PHR) shares declined in pre-market trading after the company's fiscal second-quarter results showed adjusted earnings per share falling significantly short ofWall Streetexpectations, even as revenue grew double digits and came in ahead of estimates. The mismatch between top-line strength and bottom-line disappointment drove …

Nitish Kishor | 03 September 2026

What Summit Therapeutics (NASDAQ:SMMT) Investors Should Know About the Latest HARMONi-2 Data

Summit Therapeutics (NASDAQ:SMMT) shares rose in pre-market trading after the company noted that its partner, Akeso Inc., announced positive overall survival results from the Phase 3 HARMONi-2 study. The trial, conducted entirely in China and sponsored by Akeso, evaluated ivonescimab as a monotherapy against …

Nitish Kishor | 03 September 2026

This NASDAQ Biotech Stock Craters 44% Pre-Market After Pivotal Trial Miss

A clinical-stage biopharmaceutical company saw its stock crater in pre-market trading after announcing that a late-stage study of its lead therapy for a rare, inherited neurodevelopmental disorder did not achieve statistical significance on its primary endpoint, a measure of cognitive improvement, nor on a …

Nitish Kishor | 03 September 2026

Why Is AIM ImmunoTech (NYSE American:AIM) Penny Stock Up Pre-Market Today?

AIM ImmunoTech (NYSE American:AIM) penny stock rose in pre-market trading after the company announced expanded patent protection across 18 European countries and the United Kingdom for its drug Ampligen in treating Long COVID, the persistent post-viral symptoms some patients experience following COVID-19 infection. The …

Nitish Kishor | 03 September 2026
Support

Hi! How can we help you today?

Loading…